Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.
Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Establishment and antitumor ef ...... plification and PTEN deletion.
@en
Establishment and antitumor ef ...... plification and PTEN deletion.
@nl
type
label
Establishment and antitumor ef ...... plification and PTEN deletion.
@en
Establishment and antitumor ef ...... plification and PTEN deletion.
@nl
prefLabel
Establishment and antitumor ef ...... plification and PTEN deletion.
@en
Establishment and antitumor ef ...... plification and PTEN deletion.
@nl
P2093
P2860
P356
P1433
P1476
Establishment and antitumor ef ...... plification and PTEN deletion.
@en
P2093
Byong Chang Jeong
Da Eun Jeong
Do-Hyun Nam
Han-Yong Choi
Hwang Gyun Jeon
Hye Jin Song
Hye Won Lee
Hyun Hwan Sung
Hyun Moo Lee
Joung Eun Lim
P2860
P304
51626-51639
P356
10.18632/ONCOTARGET.10539
P407
P577
2016-07-12T00:00:00Z